Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001733-41Phase 4Completed
Phase 4 trial of sodium chloride in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Harju Mika. Primary endpoint: Change in intraocular pressure after hypertonic saline dosing. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001733-41.